Broncho-munal caps 7mg #10

Broncho-munal instruction for use

You can buy Broncho-munal on this page

Clinical and pharmacological group

Immunostimulating drug of bacterial origin

Form of release, composition and packaging

Capsules hard gelatinous, size 3, opaque, with a body and a lid of blue color; the contents of the capsules are a light beige powder.

pharmachologic effect of Broncho-munal

Immunomodulating drug of bacterial origin. It has an immunostimulating effect, enhancing immunity against respiratory tract infections.
After taking the capsule, the bacterial lysate accumulates in the Peyer's patches of the gastrointestinal mucosa, in particular, located in the small intestine. Antigen presenting cells in Peyer's plaques are activated by bacterial lysate and subsequently stimulate other cell types (B-lymphocytes) responsible for specific immunity. The number of circulating B lymphocytes increases, this leads to an increase in the production of polyclonal antibodies, especially IgG serum and IgA, secreted by the mucosa of the respiratory tract and salivary glands.
Broncho-munal stimulates most leukocytes, which is characterized by an increase in the number of cells of the myeloid and lymphoid series, as well as a selective increase in the expression of receptors on the surface.
In patients receiving the drug, the protective properties of the body against bacteria and viruses are enhanced.
Clinically, Broncho-munal reduces the incidence of acute infections of the respiratory tract, shortens the duration of their course, reduces the likelihood of exacerbations of chronic bronchitis, and increases the body's resistance to infections in the respiratory system. This reduces the need for the use of other drugs, especially antibiotics.

Pharmacokinetics

Data on the pharmacokinetics of the drug are not available.

Indications

- infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in children aged 6 months to 12 years (for capsules 3.5 mg);
- infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in adults and children over the age of 12 (capsules 7 mg);
- for the prevention of recurrent infections of the respiratory tract and exacerbations of chronic bronchitis.

Contraindications of Broncho-munal

- Pregnancy;
- lactation period;
- Children's age to 6 months (for capsules 3.5 mg);
- Children under 12 years (for capsules 7 mg);
- increased individual sensitivity to the components of the drug.

Dosage

Adults and children over 12 years of age are prescribed Bronho-munal in a dose of 7 mg; Children aged 6 months to 12 years are prescribed Broncho-munal P at a dose of 3.5 mg.
Broncho-munal is taken in the morning on an empty stomach (30 minutes before meals) for 1 caps. / Day. If the patient / child can not swallow the capsule, it is recommended to open it, dissolve the contents of the capsule in a small amount of liquid (tea, milk or juice).
For the prevention of infectious diseases of the respiratory tract and exacerbation of chronic bronchitis,Broncho-munal is used for three 10-day courses with 20-day intervals between them.
In the complex therapy of acute infectious diseases of the respiratory tract, one capsule / day is used until the symptoms disappear, but not less than 10 days. In the next 2 months, a preventive use of the drug per 1 capsule is possible. for 10 days with a 20-day interval between courses.

Side effects

Broncho-munal is usually well tolerated. Most adverse reactions are classified in the general category with moderate to moderate severity. The most frequent manifestation of side effects is a disorder of the gastrointestinal tract, skin reactions and disorders of the respiratory system.
According to WHO, unwanted effects are classified according to the frequency of development as follows: very often (≥1 / 10); often (≥1 / 100, <1/10); infrequently (≥1 / 1000, <1/100); rarely (≥1 / 10,000, <1/1000); very rarely (<1/10 000); frequency is unknown (the frequency of occurrence of phenomena can not be determined on the basis of available data).
From the digestive system: often - diarrhea, abdominal pain; frequency unknown - nausea, vomiting.
From the respiratory system: often - cough; infrequently - shortness of breath.
From the skin and subcutaneous tissues: often - a rash.
Allergic reactions: infrequently - hypersensitivity reactions (rash erythematous, generalized rash, erythema, edema, eyelid edema, edema of the face, peripheral swelling, swelling, swelling of the face, itching, generalized itching); frequency unknown - hives, angioedema.
From the side of the nervous system: the frequency is unknown - the headache.
General disorders: the frequency is unknown - fever, fatigue.

Overdose

No reports of intoxication due to drug overdose. The composition of the drug and the results of studying its toxicity in animals indicate that an overdose is unlikely.

Drug Interactions

No interaction of Broncho-munal with other drugs was noted.
The drug can be used concomitantly with other medicines, including antibiotics.

special instructions

Possible manifestations of reactions of hypersensitivity to the drug.
In the case of persistent gastrointestinal disorders, skin reactions, respiratory disorders or other symptoms of intolerance to the patient, the patient should stop using Broncho-munal and consult a doctor.

Use in Pediatrics

To avoid an overdose, children between 6 months and 12 years of age should not be prescribed Bronho-moon 7 mg, intended for adults.
Impact on the ability to drive vehicles and manage mechanisms
The drug does not affect the ability to concentrate and control vehicles and mechanisms.

Pregnancy and lactemia

Studies in animals have not revealed a negative effect on the course of pregnancy. Safety and efficacy of Broncho-munal during pregnancy and during breastfeeding have not been studied, so the use of the drug during pregnancy and during lactation is contraindicated.

Application in childhood

Children aged 6 months to 12 years are prescribed Broncho-munal P at a dose of 3.5 mg.

Conditions of leave from pharmacies

To buy Broncho-munal the prescription is not required.

Terms and conditions of storage

Capsules Broncho-munal should be stored out of reach of children at a temperature of 15 ° to 25 ° C. Shelf life - 5 years.